ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
Avatar

ASCO 2022 on the Changing Landscape in Post-Transplant Treatment of Newly Diagnosed MM

By ASCO 2022 Conference Coverage FEATURING Andrzej Jakubowiak
By ASCO 2022 Conference Coverage FEATURING Andrzej Jakubowiak
66 views
July 7, 2022
0 Comments
Login to view comments. Click here to Login
Myeloma
01:26
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Post Hoc Analysis of Sustained MRD …

Feat. C. Rodriguez
04:46
ASCO 2022 Conference Coverage

ASCO 2022 on a Post Hoc Analysis of Sustained MRD Negativity From th…

Feat. C. Rodriguez
05:05
ASCO 2022 Conference Coverage

ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell Redirecting Immunot…

Feat. A. Jakubowiak
01:00
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell R…

Feat. A. Jakubowiak
07:36
ASCO 2022 Conference Coverage

ASCO 2022 on the Changing Landscape in Post-Transplant Treatment of …

Feat. A. Jakubowiak
01:07
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR …

Feat. A. Spencer
04:19
ASCO 2022 Conference Coverage

ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies…

Feat. A. Spencer
05:09
ASCO 2022 Conference Coverage

ASCO 2022 on Myeloma Developing Regimens Using Genomics (MyDRUG) Tri…

Feat. S. Kumar
50
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Myeloma Developing Regimens Using Gen…

Feat. S. Kumar
04:01
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Safety and Clinical Activity of Belantam…

Feat. A. Suvannasankha
05:20
Thomas Martin

Health-Related Quality of Life in R/R MM Treated With Teclistamab, a…

03:09
ASCO 2022 Conference Coverage

ASCO 2022 Comparative Effectiveness of Teclistamab vs. Real-World Tr…

Feat. A. Krishnan
37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Comparative Effectiveness of Teclistamab…

Feat. A. Krishnan
01:22
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Health-Related Quality of Life in R/R MM…

Feat. T. Martin
50
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL …

Feat. M. Gertz
05:05
ASCO 2022 Conference Coverage

ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL Amyloidosis: Ratio…

Feat. M. Gertz
32
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on B-PRISM: A Phase II Trial of Combinat…

Feat. O. Nadeem
05:59
ASCO 2022 Conference Coverage

ASCO 2022 on B-PRISM: A Phase II Trial of Combination of Daratumumab…

Feat. O. Nadeem
01:29
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Addition of Carfilzomib as a Thir…

Feat. C. Cerchione
11:29
ASCO 2022 Conference Coverage

ASCO 2022 on the Addition of Carfilzomib as a Third Agent in Lenalid…

Feat. C. Cerchione